virally-associated tumors

Tessa showcases preclinical promise of 'all-in-one' add-on to its cancer cell therapy, in march to the clinic
Endpoints
Fri, 05/3/19 - 10:22 am
Tessa Therapeutics
CAR-T
virally-associated tumors
cancer
cell therapy